Words of wisdom. Re: Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Scher HI, Beer TM, Higano CS, et al. Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium.
Miller
Kurt
K
Department of Urology, Charité Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. miller@medizin.fu-berlin.de